Search Tag: TAI

2025 20 Jul

  Metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease, affects around one quarter of the global population. It is characterised by hepatic steatosis in the presence of cardiometabolic risk factors and in the absence of other liver diseases or excessive alcohol consumption. A subset...Read more

2025 20 Jul

  Metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease, affects around one quarter of the global population. It is characterised by hepatic steatosis in the presence of cardiometabolic risk factors and in the absence of other liver diseases or excessive alcohol consumption. A subset...Read more